|
Volumn 19, Issue SUPPL., 2002, Pages
|
A personal history of the CAMPATH-1H antibody
|
Author keywords
Alemtuzumab; CAMPATH 1H; Leukemia, B cell, chronic; Monoclonal antibody
|
Indexed keywords
ALEMTUZUMAB;
CANCER ANTIBODY;
CD52 ANTIGEN;
GLYCOPROTEIN;
LEUKOCYTE ANTIGEN;
MONOCLONAL ANTIBODY;
TUMOR ANTIGEN;
ANTIBODY RESPONSE;
ARTICLE;
AUTOIMMUNE DISEASE;
BIOSYNTHESIS;
BONE MARROW TRANSPLANTATION;
CANCER IMMUNOTHERAPY;
CELL MEDIATED CYTOTOXICITY;
CHRONIC LYMPHATIC LEUKEMIA;
COMMERCIAL PHENOMENA;
DRUG EFFICACY;
DRUG IDENTIFICATION;
DRUG MARKETING;
DRUG TARGETING;
HISTORY OF MEDICINE;
HUMAN;
IMMUNOBIOLOGY;
IMMUNOSUPPRESSIVE TREATMENT;
IN VIVO STUDY;
KIDNEY TRANSPLANTATION;
LICENSING;
PRIORITY JOURNAL;
TARGET CELL;
B CELL LEUKEMIA;
DRUG EFFECT;
IMMUNOLOGY;
ISOLATION AND PURIFICATION;
ANTIBODIES, MONOCLONAL;
ANTIBODIES, NEOPLASM;
ANTIGENS, CD;
ANTIGENS, NEOPLASM;
BONE MARROW TRANSPLANTATION;
GLYCOPROTEINS;
HUMANS;
LEUKEMIA, B-CELL, CHRONIC;
|
EID: 0036277088
PISSN: 13570560
EISSN: None
Source Type: Journal
DOI: 10.1385/mo:19:2s:s03 Document Type: Article |
Times cited : (47)
|
References (23)
|